Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1; European Polymer Journal; Vol. 127
| Parent link: | European Polymer Journal Vol. 127.— 2020.— [109598, 9 p.] |
|---|---|
| Autor Corporativo: | Национальный исследовательский Томский политехнический университет Исследовательская школа физики высокоэнергетических процессов |
| Otros Autores: | Kibler E. V. Elina Vitaljevna, Lavrinenko A. K. Anastasiya Konstantinovna, Kolesnik I. M. Iljya Maksimovich, Stankevich K. S. Ksenia Sergeevna, Bolbasov E. N. Evgeny Nikolaevich, Kudryavtseva V. L. Valeriya Lvovna, Leonov A. A. Andrey Andreevich, Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Khlebnikov A. I. Andrey Ivanovich, Quinn M. T. Mark, Tverdokhlebov S. I. Sergei Ivanovich |
| Sumario: | Title screen Mitogen-activated protein kinases (MAPKs), including c-Jun N-terminal kinase (JNK), play important role in the regulation of pro-inflammatory cytokine secretion and signaling cascades. Therefore, JNKs are key targets for the treatment of cytokine/JNK-driven diseases. Herein, we developed electrospray poly(lactic-co-glycolic acid) (PLGA) microparticles doped with novel JNK inhibitor 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1). Optimized electrospray parameters allowed us to produce IQ-1-doped microparticles with round shape, smooth and non-porous surface, and mean diameter of 0.9-1.3 μm. We have shown that IQ-1 was well integrated into the polymer matrix and had a prolonged release in two steps via non-Fickian release. The fabricated particles doped with IQ-1 exhibited anti-inflammatory effects, as indicated by inhibited neutrophil activation and cytokine secretion by human monocytic MonoMac-6 cells. Overall, our study demonstrates that PLGA microparticles doped with a novel JNK inhibitor (IQ-1) could be a promising delivery system for treatment of JNK-mediated diseases. Режим доступа: по договору с организацией-держателем ресурса |
| Lenguaje: | inglés |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1016/j.eurpolymj.2020.109598 |
| Formato: | Electrónico Capítulo de libro |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664065 |
Ejemplares similares
Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Publicado: (2019)
Publicado: (2019)
c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Publicado: (2025)
Publicado: (2025)
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Publicado: (2023)
Publicado: (2023)
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Publicado: (2020)
Publicado: (2020)
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Publicado: (2023)
Publicado: (2023)
Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Publicado: (2021)
Publicado: (2021)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Publicado: (2019)
Publicado: (2019)
Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Publicado: (2023)
Publicado: (2023)
Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11
Publicado: (2025)
Publicado: (2025)
c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Publicado: (2019)
Publicado: (2019)
Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Publicado: (2020)
Publicado: (2020)
Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Publicado: (2024)
Publicado: (2024)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Publicado: (2018)
Publicado: (2018)
Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Publicado: (2024)
Publicado: (2024)
Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Publicado: (2023)
Publicado: (2023)
Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Publicado: (2022)
Publicado: (2022)
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Publicado: (2018)
Publicado: (2018)
Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation; Cells; Vol. 9, iss. 11
Publicado: (2020)
Publicado: (2020)
Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines; Molecules; Vol. 29, iss. 11
Publicado: (2024)
Publicado: (2024)
Physico-chemical Evaluation of Antiatherosclerotic Coronary Stent Coatings Based on Poly(lactic acid) Doped with Functionalized Fe@C Nanoparticles; BioNanoScience; Vol. 14
Publicado: (2024)
Publicado: (2024)
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Publicado: (2022)
Publicado: (2022)
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Publicado: (2023)
Publicado: (2023)
A new approach for the immobilization of poly(acrylic) acid as a chemically reactive cross-linker on the surface of poly(lactic) acid-based biomaterials; Materials Science and Engineering: C; Vol. 71
Publicado: (2017)
Publicado: (2017)
3D-printed biodegradable composite poly(lactic acid)-based scaffolds with a shape memory effect for bone tissue engineering; Advanced Composites and Hybrid Materials; Vol. 8, iss. 1
Publicado: (2025)
Publicado: (2025)
Manufacturing poly(lactic acid)/metal composites and their characterization; International Journal of Advanced Manufacturing Technology; Vol. 102, iss. 9-12
por: Lebedev S. M. Sergey Mikhailovich
Publicado: (2019)
por: Lebedev S. M. Sergey Mikhailovich
Publicado: (2019)
Preparation of Poly(L-lactic acid)/Hydroxyapatite composite scaffolds by fused deposit modeling 3D printing; Materials Today: Proceedings; Vol. 22, Pt. 2 : 2nd International Conference on Nanomaterials and Biomaterials (ICNB 2018)
Publicado: (2020)
Publicado: (2020)
Biological Effect of the Surface Modification of the Fibrous Poly(L-lactic acid) Scaffolds by Radio Frequency Magnetron Sputtering of Different Calcium-Phosphate Targets; BioNanoScience; Vol. 7, iss. 1
Publicado: (2017)
Publicado: (2017)
Deposition of cellulose acetate coatings on titanium substrates by electrospraying for biomedical applications; Surface and Coatings Technology; Vol. 494, pt. 2
Publicado: (2024)
Publicado: (2024)
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25; European Journal of Medicinal Chemistry; Vol. 183
Publicado: (2019)
Publicado: (2019)
Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime; Pharmaceutics; Vol. 15, iss. 7
Publicado: (2023)
Publicado: (2023)
Revealing an important role of piezoelectric polymers in nervous-tissue regeneration: A review; Materials Today Bio; Vol. 25
Publicado: (2024)
Publicado: (2024)
JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S; Biochemistry (Moscow); Vol. 90, iss. 2
Publicado: (2025)
Publicado: (2025)
Surface Modification of PLLA Electrospun Nanofiber Materials for Biomedical Applications; BioNanoScience; Vol. 8, iss. 1
Publicado: (2018)
Publicado: (2018)
Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S); Cells; Vol. 14, iss. 12
Publicado: (2025)
Publicado: (2025)
The IQ-1S JNK (c-Jun N-Terminal Kinase) Inhibitor Suppresses Premature Aging of OXYS Rat Brain; Neurochemical Journal; Vol. 17, iss. 3
Publicado: (2023)
Publicado: (2023)
Система доставки IQ-1 на основе PLGA микрочастиц, полученных методом электрораспыления; Физико-технические проблемы в науке, промышленности и медицине (ФТПНПМ-2019)
Publicado: (2019)
Publicado: (2019)
Effect of Intermediate Ion Cleaning of the Titanium Target on the Structure of Bioresorbable PLLA Scaffolds under Coating Deposition by DC Reactive Magnetron Sputtering; Inorganic Materials: Applied Research; Vol. 11, iss. 3
Publicado: (2020)
Publicado: (2020)
Mechanical properties of PLA-based composites for fused deposition modeling technology; International Journal of Advanced Manufacturing Technology; Vol. 97, iss. 1-4
Publicado: (2018)
Publicado: (2018)
Перспективная система доставки IQ-1 на основе полимерных частиц, полученных методом электрораспыления; Химия и химическая технология в XXI веке
Publicado: (2020)
Publicado: (2020)
Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential; Biomolecules; Vol. 11, iss. 6
Publicado: (2021)
Publicado: (2021)
Ejemplares similares
-
Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Publicado: (2019) -
c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Publicado: (2025) -
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Publicado: (2023) -
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Publicado: (2020) -
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Publicado: (2023)